|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of AKT1 mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 6:137,534,810...137,555,131
|
|
G |
Alb |
albumin |
decreases expression increases secretion affects expression |
EXP ISO |
ceric oxide results in decreased expression of ALB protein ceric oxide results in increased secretion of ALB protein ceric oxide affects the expression of ALB mRNA |
CTD |
PMID:22072870 PMID:23726862 PMID:29463257 |
|
NCBI chr14:17,891,564...17,907,043
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of AP3D1 mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 7:8,970,249...9,005,651
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
ceric oxide results in increased expression of APAF1 protein |
CTD |
PMID:24987704 |
|
NCBI chr 7:27,381,392...27,466,772
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
ceric oxide results in increased expression of BAX protein |
CTD |
PMID:24987704 |
|
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
ceric oxide results in decreased expression of BCL2 protein [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of BCL2 protein |
CTD |
PMID:24987704 PMID:36982514 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
EXP |
ceric oxide results in increased expression of BIRC5 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:103,567,369...103,580,069
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
EXP |
ceric oxide results in decreased expression of BRCA1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:86,917,693...86,978,012
|
|
G |
Car9 |
carbonic anhydrase 9 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CA9 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of CA9 protein |
CTD |
PMID:36982514 |
|
NCBI chr 5:62,559,024...62,565,626
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases expression |
ISO |
ceric oxide results in increased cleavage of CASP3 protein ceric oxide results in increased expression of CASP3 protein |
CTD |
PMID:24987704 PMID:26028148 |
|
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casp7 |
caspase 7 |
affects expression |
ISO |
ceric oxide analog affects the expression of CASP7 mRNA |
CTD |
PMID:22960666 |
|
NCBI chr 1:265,442,647...265,481,938
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
ceric oxide results in increased expression of CASP9 protein |
CTD |
PMID:24987704 |
|
|
|
G |
Cat |
catalase |
decreases activity multiple interactions affects expression |
ISO EXP |
ceric oxide results in decreased activity of CAT protein Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein] ceric oxide affects the expression of CAT protein |
CTD |
PMID:20457660 PMID:23416263 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions increases expression |
ISO EXP |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL11 mRNA; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL11 protein; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL11 mRNA] ceric oxide results in increased expression of CCL11 mRNA |
CTD |
PMID:29463257 PMID:29792201 |
|
NCBI chr10:67,525,975...67,530,576
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
multiple interactions increases expression |
ISO EXP |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL17 mRNA ceric oxide results in increased expression of CCL17 mRNA |
CTD |
PMID:29463257 PMID:29792201 |
|
NCBI chr19:10,208,120...10,218,340
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion increases expression |
ISO EXP |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL2 mRNA ceric oxide results in increased secretion of CCL2 protein ceric oxide results in increased expression of CCL2 mRNA |
CTD |
PMID:29463257 PMID:29792201 |
|
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
multiple interactions affects expression |
ISO EXP |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL20 mRNA ceric oxide affects the expression of CCL20 mRNA |
CTD |
PMID:29463257 PMID:29792201 |
|
NCBI chr 9:91,837,139...91,839,736
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
increases expression |
EXP |
ceric oxide results in increased expression of CCL22 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr19:10,263,589...10,270,359
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
increases expression |
EXP |
ceric oxide results in increased expression of CCL24 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr12:21,100,835...21,104,832
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL26 mRNA |
CTD |
PMID:29792201 |
|
NCBI chr12:26,745,972...26,750,924
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
EXP |
ceric oxide results in increased expression of CCL3 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
EXP |
ceric oxide results in increased expression of CCL4 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:68,963,893...68,965,728
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
EXP |
ceric oxide results in increased expression of CCL7 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:67,514,095...67,515,945
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
EXP |
ceric oxide results in increased expression of CCR2 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Cd177 |
CD177 molecule |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CD177 mRNA |
CTD |
PMID:29792201 |
|
NCBI chr 1:80,340,034...80,360,599
|
|
G |
Cd40lg |
CD40 ligand |
decreases expression |
EXP |
ceric oxide results in decreased expression of CD40LG mRNA |
CTD |
PMID:29463257 |
|
NCBI chr X:140,164,341...140,176,057
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
ISO |
ceric oxide results in increased expression of CD63 protein |
CTD |
PMID:23726862 |
|
NCBI chr 7:1,325,108...1,340,447
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CDKN1A mRNA; [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CDKN1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of CDKN1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in increased expression of CDKN1A protein |
CTD |
PMID:36982514 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CDKN1B protein |
CTD |
PMID:36982514 |
|
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Clca1 |
chloride channel accessory 1 |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CLCA1 protein] |
CTD |
PMID:29792201 |
|
NCBI chr 2:233,938,677...233,964,369
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLEC10A mRNA |
CTD |
PMID:29792201 |
|
NCBI chr10:55,374,914...55,379,110
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
EXP |
ceric oxide results in increased expression of CX3CL1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr19:10,233,326...10,244,856
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
affects expression |
EXP |
ceric oxide affects the expression of CX3CR1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 8:128,661,294...128,679,048
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CXCL10 mRNA] |
CTD |
PMID:29792201 |
|
NCBI chr14:15,989,066...15,991,263
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
EXP |
ceric oxide results in decreased expression of CXCL12 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 4:152,060,781...152,073,628
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
affects expression |
EXP |
ceric oxide affects the expression of CXCL9 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr14:16,007,166...16,012,077
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
increases expression |
EXP |
ceric oxide results in increased expression of CXCR2 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 9:83,178,645...83,185,017
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
increases expression |
EXP |
ceric oxide results in increased expression of CXCR3 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr X:70,884,293...70,886,944
|
|
G |
Cxcr5 |
C-X-C motif chemokine receptor 5 |
decreases expression |
EXP |
ceric oxide results in decreased expression of CXCR5 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 8:53,738,878...53,756,813
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CYP1A1 mRNA; [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CYP1A1 protein; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:29792201 PMID:36982514 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
affects expression |
EXP |
ceric oxide affects the expression of CYP1B1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 6:21,093,927...21,103,091
|
|
G |
Dbnl |
drebrin-like |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of DBNL mRNA |
CTD |
PMID:24821434 |
|
NCBI chr14:80,666,115...80,681,155
|
|
G |
Dkk4 |
dickkopf WNT signaling pathway inhibitor 4 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of DKK4 protein |
CTD |
PMID:36982514 |
|
NCBI chr16:69,403,215...69,406,580
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of EPAS1 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of EPAS1 protein |
CTD |
PMID:36982514 |
|
NCBI chr 6:13,543,252...13,626,147
|
|
G |
Epx |
eosinophil peroxidase |
decreases expression |
EXP |
ceric oxide results in decreased expression of EPX mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:73,164,096...73,175,180
|
|
G |
Exo1 |
exonuclease 1 |
affects expression |
EXP |
ceric oxide affects the expression of EXO1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr13:87,809,725...87,834,654
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
EXP |
ceric oxide results in increased expression of FABP4 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 2:93,488,251...93,492,961
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
EXP |
ceric oxide results in decreased expression of GCLC mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 8:87,510,251...87,548,896
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
EXP |
ceric oxide results in decreased expression of GCLM mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 2:213,032,135...213,052,192
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
EXP |
ceric oxide results in decreased expression of GPX2 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 6:101,226,745...101,230,033
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
EXP |
ceric oxide results in decreased expression of HBA1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:15,828,291...15,829,138
|
|
G |
Hfe |
homeostatic iron regulator |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of HFE mRNA |
CTD |
PMID:24821434 |
|
NCBI chr17:41,413,451...41,421,502
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of HIF1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of HIF1A protein |
CTD |
PMID:36982514 |
|
NCBI chr 6:98,357,788...98,405,068
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression increases expression decreases expression multiple interactions |
ISO |
ceric oxide analog affects the expression of HMOX1 mRNA ceric oxide results in increased expression of HMOX1 protein ceric oxide results in decreased expression of HMOX1 mRNA ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] |
CTD |
PMID:19429248 PMID:22960666 PMID:25618551 |
|
NCBI chr19:13,452,365...13,479,823
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of ID2 mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 6:47,469,162...47,470,995
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL13 mRNA] |
CTD |
PMID:29792201 |
|
NCBI chr10:38,290,926...38,293,483
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
EXP |
ceric oxide results in increased expression of IL1A mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
EXP |
ceric oxide results in increased expression of IL1B mRNA; ceric oxide results in increased expression of IL1B protein |
CTD |
PMID:21624445 PMID:29463257 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases expression |
EXP |
ceric oxide results in increased expression of IL1RN mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
decreases expression |
EXP |
ceric oxide results in decreased expression of IL2RB mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 7:111,913,828...111,928,537
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
increases expression |
EXP |
ceric oxide results in increased expression of IL2RG mRNA |
CTD |
PMID:29463257 |
|
NCBI chr X:66,395,330...66,399,026
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL4 mRNA] |
CTD |
PMID:29792201 |
|
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
ceric oxide results in increased expression of IL6 protein [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of IL6 mRNA |
CTD |
PMID:21624445 PMID:29792201 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Irf7 |
interferon regulatory factor 7 |
multiple interactions |
ISO |
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IRF7 mRNA] |
CTD |
PMID:29792201 |
|
NCBI chr 1:205,796,956...205,800,543
|
|
G |
Kif13b |
kinesin family member 13B |
increases expression |
ISO |
ceric oxide analog results in increased expression of KIF13B mRNA |
CTD |
PMID:24821434 |
|
NCBI chr15:38,908,257...39,066,021
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
ceric oxide analog results in increased expression of KITLG mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 7:36,782,621...36,863,796
|
|
G |
Lig4 |
DNA ligase 4 |
affects expression |
EXP |
ceric oxide affects the expression of LIG4 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr16:86,220,345...86,228,930
|
|
G |
Lpo |
lactoperoxidase |
increases expression |
EXP |
ceric oxide results in increased expression of LPO mRNA; ceric oxide results in increased expression of LPO protein |
CTD |
PMID:29463257 |
|
NCBI chr10:72,606,950...72,626,220
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
ceric oxide results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:23416263 |
|
NCBI chr11:97,462,025...97,529,193
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:23416263 |
|
NCBI chr 1:190,797,189...190,803,411
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
multiple interactions increases expression |
ISO EXP |
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of MMP12 mRNA] ceric oxide results in increased expression of MMP12 mRNA; ceric oxide results in increased expression of MMP12 protein |
CTD |
PMID:29463257 PMID:29792201 |
|
NCBI chr 8:12,866,652...12,876,554
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases activity increases secretion |
ISO |
ceric oxide results in increased activity of MMP9 protein ceric oxide results in increased secretion of MMP9 protein |
CTD |
PMID:23726862 |
|
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Mpo |
myeloperoxidase |
increases secretion increases expression |
ISO EXP |
ceric oxide results in increased secretion of MPO protein ceric oxide results in increased expression of MPO mRNA |
CTD |
PMID:23726862 PMID:29463257 |
|
NCBI chr10:73,092,124...73,102,057
|
|
G |
Msh5 |
mutS homolog 5 |
increases expression |
EXP |
ceric oxide results in increased expression of MSH5 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr20:3,779,180...3,797,996
|
|
G |
Muc1 |
mucin 1, cell surface associated |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC1 mRNA |
CTD |
PMID:29792201 |
|
NCBI chr 2:176,933,312...176,938,497
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC5AC mRNA |
CTD |
PMID:29792201 |
|
NCBI chr 1:206,293,717...206,326,006
|
|
G |
Mutyh |
mutY DNA glycosylase |
decreases expression |
EXP |
ceric oxide results in decreased expression of MUTYH mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 5:135,510,666...135,522,777
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression decreases expression |
EXP |
ceric oxide results in increased expression of NCF2 mRNA ceric oxide results in decreased expression of NCF2 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr13:67,505,492...67,536,015
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization |
ISO |
ceric oxide affects the localization of NFE2L2 protein |
CTD |
PMID:19429248 |
|
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of NFKB1 protein |
CTD |
PMID:36982514 |
|
NCBI chr 2:226,689,745...226,805,897
|
|
G |
Ngb |
neuroglobin |
decreases expression |
EXP |
ceric oxide results in decreased expression of NGB mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 6:112,475,332...112,480,786
|
|
G |
Noxo1 |
NADPH oxidase organizer 1 |
increases expression |
EXP |
ceric oxide results in increased expression of NOXO1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr10:14,226,473...14,230,541
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of NQO1 mRNA |
CTD |
PMID:29792201 |
|
NCBI chr19:52,205,374...52,220,267
|
|
G |
Opcml |
opioid binding protein/cell adhesion molecule-like |
increases expression |
EXP |
ceric oxide results in increased expression of OPCML mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 8:26,788,988...27,304,551
|
|
G |
Osm |
oncostatin M |
affects expression |
EXP |
ceric oxide affects the expression of OSM mRNA |
CTD |
PMID:29463257 |
|
NCBI chr14:83,327,202...83,332,073
|
|
G |
Pf4 |
platelet factor 4 |
increases expression |
EXP |
ceric oxide results in increased expression of PF4 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr14:17,582,477...17,583,392
|
|
G |
Pon3 |
paraoxonase 3 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein |
CTD |
PMID:36982514 |
|
NCBI chr 4:34,323,546...34,350,244
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased oxidation of PRDX1 protein modified form; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased oxidation of PRDX1 protein modified form |
CTD |
PMID:36982514 |
|
NCBI chr 5:135,383,906...135,399,504
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of HLA-A mRNA |
CTD |
PMID:24821434 |
|
NCBI chr20:3,261,656...3,265,548
|
|
G |
Scd |
stearoyl-CoA desaturase |
affects expression |
EXP |
ceric oxide affects the expression of SCD1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 1:253,218,968...253,232,101
|
|
G |
Sectm1b |
secreted and transmembrane 1B |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of SECTM1 mRNA |
CTD |
PMID:24821434 |
|
NCBI chr10:106,822,397...106,832,105
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of SIRT2 protein |
CTD |
PMID:36982514 |
|
NCBI chr 1:93,181,472...93,204,499
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of SLC26A4 mRNA] |
CTD |
PMID:29792201 |
|
NCBI chr 6:48,107,575...48,153,762
|
|
G |
Smug1 |
single-strand-selective monofunctional uracil-DNA glycosylase 1 |
increases expression |
EXP |
ceric oxide results in increased expression of SMUG1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 7:134,288,565...134,302,179
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO |
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of SOD2 protein; ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] ceric oxide results in increased expression of SOD2 mRNA |
CTD |
PMID:25618551 PMID:36982514 |
|
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
ceric oxide results in decreased expression of SPP1 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr14:5,613,569...5,620,695
|
|
G |
Tafazzin |
tafazzin, phospholipid-lysophospholipid transacylase |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of TAFAZZIN mRNA |
CTD |
PMID:24821434 |
|
NCBI chr X:152,065,539...152,076,178
|
|
G |
Tirap |
TIR domain containing adaptor protein |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of TIRAP mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 8:41,789,557...41,805,903
|
|
G |
Tlr6 |
toll-like receptor 6 |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of TLR6 mRNA |
CTD |
PMID:24821434 |
|
NCBI chr14:43,715,809...43,727,019
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
EXP ISO |
ceric oxide results in increased expression of TNF protein |
CTD |
PMID:21624445 PMID:27693598 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfsf4 |
TNF superfamily member 4 |
affects expression |
EXP |
ceric oxide affects the expression of TNFSF4 mRNA |
CTD |
PMID:29463257 |
|
NCBI chr13:76,256,654...76,280,133
|
|
G |
Tollip |
toll interacting protein |
decreases expression |
ISO |
ceric oxide analog results in decreased expression of TOLLIP mRNA |
CTD |
PMID:24821434 |
|
NCBI chr 1:196,961,585...196,984,252
|
|
G |
Tp53 |
tumor protein p53 |
increases phosphorylation multiple interactions |
ISO |
ceric oxide results in increased phosphorylation of TP53 protein [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of TP53 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in increased expression of TP53 protein |
CTD |
PMID:24987704 PMID:36982514 |
|
NCBI chr10:54,798,871...54,810,300
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of TSLP mRNA |
CTD |
PMID:29792201 |
|
NCBI chr18:24,723,990...24,728,419
|
|
G |
Txnip |
thioredoxin interacting protein |
decreases expression |
EXP |
ceric oxide results in decreased expression of TXNIP mRNA |
CTD |
PMID:29463257 |
|
NCBI chr 2:186,781,933...186,785,736
|
|
|
G |
Alb |
albumin |
affects expression |
ISO |
cerous chloride affects the expression of ALB mRNA |
CTD |
PMID:23139204 |
|
NCBI chr14:17,891,564...17,907,043
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of ALOX12 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of ALOX12 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:55,456,923...55,469,239
|
|
G |
Aox1 |
aldehyde oxidase 1 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of AOX1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 9:67,073,831...67,152,980
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
ISO |
cerous chloride affects the expression of APOA4 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 8:55,435,779...55,438,160
|
|
G |
Apoe |
apolipoprotein E |
affects expression multiple interactions |
ISO |
cerous chloride affects the expression of APOE mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of APOE mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:88,481,889...88,485,816
|
|
G |
B2m |
beta-2 microglobulin |
increases expression |
ISO |
cerous chloride results in increased expression of B2M mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:129,549,236...129,555,354
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of CAT mRNA cerous chloride results in decreased expression of CAT mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression multiple interactions |
ISO |
cerous chloride results in increased expression of CCL5 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:68,820,330...68,824,906
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] affects the expression of CCS mRNA cerous chloride results in decreased expression of CCS mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:202,113,792...202,134,931
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
cerous chloride results in decreased expression of CDKN1A mRNA |
CTD |
PMID:23139204 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
cerous chloride results in increased expression of CEL mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 3:11,883,532...11,891,035
|
|
G |
Cfd |
complement factor D |
affects expression |
ISO |
cerous chloride affects the expression of CFD mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 7:10,463,773...10,465,496
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
increases expression |
ISO |
cerous chloride results in increased expression of CHUK mRNA; cerous chloride results in increased expression of CHUK protein |
CTD |
PMID:21656643 |
|
NCBI chr 1:252,908,748...252,944,273
|
|
G |
Cygb |
cytoglobin |
affects expression multiple interactions |
ISO |
cerous chloride affects the expression of CYGB mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of CYGB mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:101,877,675...101,887,442
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
cerous chloride results in increased expression of CYP1A1 |
CTD |
PMID:23712967 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
affects expression |
ISO |
cerous chloride affects the expression of CYP51 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 4:30,036,956...30,055,410
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
increases expression |
ISO |
cerous chloride results in increased expression of CYP7B1 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 2:102,419,011...102,586,047
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
affects expression |
ISO |
cerous chloride affects the expression of CYP8B1 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 8:130,455,622...130,457,592
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
cerous chloride results in decreased expression of DHCR24 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 5:126,573,366...126,599,940
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression |
ISO |
cerous chloride affects the expression of DHCR7 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 1:208,444,434...208,460,408
|
|
G |
Duox1 |
dual oxidase 1 |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of DUOX1 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:109,260,526...109,295,588
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:109,223,809...109,247,023
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions affects expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUSP1 mRNA cerous chloride affects the expression of DUSP1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:17,184,853...17,187,646
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
affects expression |
ISO |
cerous chloride affects the expression of EBP mRNA |
CTD |
PMID:23139204 |
|
NCBI chr X:14,299,427...14,305,826
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
affects expression |
ISO |
cerous chloride affects the expression of EHHADH mRNA |
CTD |
PMID:23139204 |
|
NCBI chr11:92,746,409...92,779,647
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
affects expression multiple interactions |
ISO |
cerous chloride affects the expression of EPHX2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of EPHX2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr15:44,465,447...44,503,157
|
|
G |
Epx |
eosinophil peroxidase |
decreases expression |
ISO |
cerous chloride results in decreased expression of EPX mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:73,164,096...73,175,180
|
|
G |
Foxm1 |
forkhead box M1 |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of FOXM1 mRNA cerous chloride results in decreased expression of FOXM1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 4:163,325,628...163,338,100
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
cerous chloride results in increased expression of FTH1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:216,052,037...216,054,325
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of GAPDH mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of GAPDH mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 4:159,648,592...159,653,436
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
cerous chloride results in increased expression of GCLC mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of GCLC mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 8:87,510,251...87,548,896
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
ISO |
cerous chloride results in decreased expression of GCLM mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 2:213,032,135...213,052,192
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
affects expression |
ISO |
cerous chloride affects the expression of GPD2 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 3:41,800,552...41,937,729
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
ISO |
cerous chloride results in decreased expression of GPX2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 6:101,226,745...101,230,033
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
multiple interactions affects expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of GPX3 mRNA cerous chloride affects the expression of GPX3 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:39,529,335...39,537,406
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
affects expression |
ISO |
cerous chloride affects the expression of GPX4 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 7:10,300,833...10,303,629
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of GPX7 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of GPX7 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 5:123,145,151...123,153,141
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
affects expression |
ISO |
cerous chloride affects the expression of GRB2 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr10:101,380,354...101,448,138
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
cerous chloride results in decreased expression of GSTP1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:210,767,237...210,770,242
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of GSTZ1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 6:106,794,594...106,805,284
|
|
G |
Gtf2i |
general transcription factor II I |
decreases expression |
ISO |
cerous chloride results in decreased expression of GTF2I mRNA |
CTD |
PMID:28954213 |
|
NCBI chr12:22,400,933...22,476,243
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions affects expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of HMOX1 mRNA cerous chloride affects the expression of HMOX1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr19:13,452,365...13,479,823
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
decreases expression |
ISO |
cerous chloride results in decreased expression of HSPA1A mRNA |
CTD |
PMID:28954213 |
|
NCBI chr20:3,875,411...3,877,866
|
|
G |
Ifng |
interferon gamma |
increases expression |
ISO |
cerous chloride results in increased expression of IFNG |
CTD |
PMID:23712967 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
increases expression |
ISO |
cerous chloride results in increased expression of IKBKB mRNA; cerous chloride results in increased expression of IKBKB protein |
CTD |
PMID:21656643 |
|
NCBI chr16:76,021,968...76,075,717
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
cerous chloride results in increased expression of IL10 |
CTD |
PMID:23712967 |
|
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
cerous chloride results in increased expression of IL18 |
CTD |
PMID:23712967 |
|
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
cerous chloride results in increased expression of IL1B |
CTD |
PMID:23712967 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il2 |
interleukin 2 |
decreases expression increases expression |
ISO |
cerous chloride results in decreased expression of IL2 mRNA; cerous chloride results in decreased expression of IL2 protein cerous chloride results in increased expression of IL2 |
CTD |
PMID:21656643 PMID:23712967 |
|
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
cerous chloride results in increased expression of IL4 |
CTD |
PMID:23712967 |
|
NCBI chr10:38,272,003...38,277,549
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
IL6 mutant form inhibits the reaction [cerous chloride results in increased expression of SAA protein] cerous chloride results in increased expression of IL6; cerous chloride results in increased expression of IL6 protein |
CTD |
PMID:16204935 PMID:23712967 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression |
ISO |
cerous chloride affects the expression of JUN mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 5:115,009,900...115,012,993
|
|
G |
Lpo |
lactoperoxidase |
multiple interactions increases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of LPO mRNA cerous chloride results in increased expression of LPO mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:72,606,950...72,626,220
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
cerous chloride results in increased expression of MAP1LC3B protein |
CTD |
PMID:38253231 |
|
NCBI chr19:66,571,631...66,582,270
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
increases expression |
ISO |
cerous chloride results in increased expression of MAP4K4 mRNA; cerous chloride results in increased expression of MAP4K4 protein |
CTD |
PMID:21656643 |
|
NCBI chr 9:42,200,708...42,326,708
|
|
G |
Mb |
myoglobin |
increases expression multiple interactions |
ISO |
cerous chloride results in increased expression of MB mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of MB mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 7:110,640,511...110,647,742
|
|
G |
Mbl2 |
mannose binding lectin 2 |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of MBL2 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of MBL2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:237,429,873...237,465,567
|
|
G |
Mif |
macrophage migration inhibitory factor |
increases expression |
ISO |
cerous chloride results in increased expression of MIF |
CTD |
PMID:23712967 |
|
NCBI chr20:12,767,138...12,791,222
|
|
G |
Mpo |
myeloperoxidase |
affects expression |
ISO |
cerous chloride affects the expression of MPO mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:73,092,124...73,102,057
|
|
G |
Mpv17 |
mitochondrial inner membrane protein MPV17 |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of MPV17 mRNA cerous chloride results in decreased expression of MPV17 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 6:25,221,668...25,236,241
|
|
G |
Msra |
methionine sulfoxide reductase A |
decreases expression |
ISO |
cerous chloride results in decreased expression of MSRA mRNA |
CTD |
PMID:28954213 |
|
NCBI chr15:42,514,818...42,853,278
|
|
G |
Mt1 |
metallothionein 1 |
increases expression multiple interactions |
ISO |
cerous chloride results in increased expression of MT1 protein cerous chloride promotes the reaction [Zinc binds to MT1 protein] |
CTD |
PMID:15964310 PMID:16204935 |
|
NCBI chr19:10,831,959...10,832,975
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
cerous chloride promotes the reaction [Zinc binds to MT2 protein] cerous chloride results in increased expression of MT2 protein |
CTD |
PMID:15964310 PMID:16204935 |
|
NCBI chr19:10,837,934...10,838,708
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr12:28,121,816...28,131,080
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
affects expression multiple interactions |
ISO |
cerous chloride affects the expression of NCF2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr13:67,505,492...67,536,015
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression |
ISO |
cerous chloride results in increased expression of NFKB1 mRNA; cerous chloride results in increased expression of NFKB1 protein |
CTD |
PMID:21656643 |
|
NCBI chr 2:226,689,745...226,805,897
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
increases expression |
ISO |
cerous chloride results in increased expression of NFKB2 mRNA; cerous chloride results in increased expression of NFKB2 protein |
CTD |
PMID:21656643 |
|
NCBI chr 1:255,106,010...255,114,649
|
|
G |
Nfkbib |
NFKB inhibitor beta |
decreases expression |
ISO |
cerous chloride results in decreased expression of NFKBIB mRNA; cerous chloride results in decreased expression of NFKBIB protein |
CTD |
PMID:21656643 |
|
NCBI chr 1:93,173,817...93,181,387
|
|
G |
Nnmt |
nicotinamide N-methyltransferase |
affects expression |
ISO |
cerous chloride affects the expression of NNMT mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 8:57,820,156...57,851,301
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of NOS2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of NOS2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:64,313,335...64,349,221
|
|
G |
Npm1 |
nucleophosmin 1 |
multiple interactions |
ISO |
cerous chloride results in decreased expression of and affects the localization of NPM1 protein |
CTD |
PMID:38253231 |
|
NCBI chr10:17,741,512...17,751,626
|
|
G |
Nt5e |
5' nucleotidase, ecto |
decreases expression |
ISO |
cerous chloride results in decreased expression of NT5E mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 8:98,150,925...98,195,646
|
|
G |
Nudt1 |
nudix hydrolase 1 |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of NUDT1 mRNA cerous chloride results in decreased expression of NUDT1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr12:14,302,514...14,309,559
|
|
G |
Pcna |
proliferating cell nuclear antigen |
affects expression multiple interactions |
ISO |
cerous chloride affects the expression of PCNA protein [cerous chloride co-treated with lanthanum chloride] affects the expression of PCNA protein |
CTD |
PMID:28954213 |
|
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
cerous chloride results in decreased expression of PNKP mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:95,341,465...95,346,921
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PRDX1 mRNA cerous chloride results in decreased expression of PRDX1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 5:135,383,906...135,399,504
|
|
G |
Prdx2 |
peroxiredoxin 2 |
decreases expression |
ISO |
cerous chloride results in decreased expression of PRDX2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr19:40,085,788...40,091,083
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of PRDX5 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:213,529,042...213,532,787
|
|
G |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PREX1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:175,724,939...175,875,764
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
cerous chloride results in decreased expression of PTGS2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr13:64,714,063...64,722,320
|
|
G |
Pxdn |
peroxidasin |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PXDN mRNA cerous chloride results in decreased expression of PXDN mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 6:46,580,749...46,658,345
|
|
G |
Rad51 |
RAD51 recombinase |
multiple interactions |
ISO |
[cerous chloride co-treated with Cisplatin] results in increased expression of RAD51 protein |
CTD |
PMID:38253231 |
|
NCBI chr 3:126,554,210...126,578,888
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression |
ISO |
cerous chloride results in increased expression of RELA mRNA; cerous chloride results in increased expression of RELA protein |
CTD |
PMID:21656643 |
|
NCBI chr 1:212,354,336...212,364,815
|
|
G |
Scara3 |
scavenger receptor class A, member 3 |
decreases expression |
ISO |
cerous chloride results in decreased expression of SCARA3 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr15:44,315,422...44,348,416
|
|
G |
Selenop |
selenoprotein P |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SELENOP mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 2:54,225,736...54,236,022
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions decreases expression increases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SIRT2 mRNA cerous chloride results in decreased expression of SIRT2 mRNA cerous chloride results in increased expression of SIRT2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:93,181,472...93,204,499
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity |
ISO |
cerous chloride results in decreased activity of SOD1 protein |
CTD |
PMID:15964310 |
|
NCBI chr11:42,942,742...42,948,399
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases activity multiple interactions |
ISO |
cerous chloride results in decreased activity of SOD2 protein [cerous chloride co-treated with lanthanum chloride] results in increased expression of SOD2 mRNA |
CTD |
PMID:15964310 PMID:28954213 |
|
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions affects expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SQSTM1 mRNA cerous chloride affects the expression of SQSTM1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr10:35,026,598...35,037,750
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions |
ISO |
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SRXN1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 3:161,064,812...161,070,372
|
|
G |
Stk25 |
serine/threonine kinase 25 |
decreases expression multiple interactions |
ISO |
cerous chloride results in decreased expression of STK25 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of STK25 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 9:94,161,834...94,174,095
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
cerous chloride results in increased expression of TGFB1 |
CTD |
PMID:23712967 |
|
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
cerous chloride results in increased expression of TLR2 mRNA; cerous chloride results in increased expression of TLR2 protein |
CTD |
PMID:21656643 |
|
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
increases expression |
ISO |
cerous chloride results in increased expression of TLR4 mRNA; cerous chloride results in increased expression of TLR4 protein |
CTD |
PMID:21656643 |
|
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
cerous chloride results in increased expression of TNF; cerous chloride results in increased expression of TNF mRNA; cerous chloride results in increased expression of TNF protein |
CTD |
PMID:21656643 PMID:23712967 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
cerous chloride results in increased expression of TXN mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 5:77,507,455...77,519,685
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
cerous chloride results in increased expression of TXNRD1 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 7:22,717,620...22,802,553
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
decreases expression |
ISO |
cerous chloride results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr11:96,024,321...96,072,475
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions decreases expression |
ISO |
[cerous chloride co-treated with lanthanum chloride] affects the expression of UCP2 mRNA cerous chloride results in decreased expression of UCP2 mRNA |
CTD |
PMID:28954213 |
|
NCBI chr 1:164,251,373...164,257,742
|
|
G |
Zap70 |
zeta chain of T cell receptor associated protein kinase 70 |
affects expression |
ISO |
cerous chloride affects the expression of ZAP70 mRNA |
CTD |
PMID:23139204 |
|
NCBI chr 9:46,485,605...46,507,552
|
|